Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
复制标题
2,3-二脱氢-2,3-双脱氧-5-氟胞苷 (D4FC) 类似物的合成和生物学评价:发现对 HIV-1 逆转录酶具有有效抑制活性的碳环核苷三磷酸。
DOI:
10.1021/jm980510s
复制
发表时间:
1999
影响因子:
7.3
通讯作者:
Schinazi,RF
中科院分区:
文献类型:
--
作者:
Shi,J;McAtee,JJ;SchlueterWirtz,S;Tharnish,P;Juodawlkis,A;Liotta,DC;Schinazi,RF
The discovery of a novel cytosine nucleoside, β-d-2‘,3‘-didehydro-2‘,3‘-dideoxy-5-fluorocytidine (d-D4FC), as a potent antihuman immunodeficiency virus (HIV) agent led us to synthesize a series of analogues and derivatives of β-d-D4FC that could be more selective and also possess increased glycosidic bond stability. The synthesizedd-D4FC analogues were evaluated for anti-HIV-1 activity, anticancer activity, and cytotoxicity in various cells. The biological data demonstrated that the 5-substitution of β-d-D4FC with bromine (6c) and iodine (6d) resulted in the loss of antiviral activity, and the α-danomer (7a) ofd-D4FC was also devoid of activity. The 5-fluorouracil analogues (6band7b) ofd-D4FC were less potent and more cytotoxic than the parent compound, whereas the β-l-D4FU (11) showed both potent anti-HIV-1 activity and cytotoxicity.N4- and 5‘-O-acyl derivatives (17,15a−c) of β-d-D4FC exhibited comparable antiviral activity to β-d-D4FC. In contrast, theN4-isopropyl derivative (20) of β-d-D4FC was not active against HIV-1, even at 100 μM. The carbocyclic analogues (26a,b) of D4FC demonstrated weak activity against HIV-1 and no toxicity in various cells. The triphosphates (27a,b) of the carbocyclic nucleosides demonstrated potent inhibitory activity against recombinant HIV-1 reverse transcriptase at submicromolar concentrations. Of the compounds tested as potential anticancer agents, β-d-, α-d-, and β-l-D4FU (6b,7b,11) showed inhibitory activity against rat glioma and modest activity against human lung carcinoma, lymphoblastoid, and skin melanoma cells.